Skip to main content
Premium Trial:

Request an Annual Quote

Change is Good?


Usually citing a need for a moniker that better describes their mission, companies in the genomics sector seem to come up with new names as often as DNA replicates itself. Here we’ve listed 20 companies or organizations that either changed their name or merged under a new one in the years since GT has been covering this sector. See if you can match each new company name in the right column with its former self in the left column. Think the new name makes the corporate agenda any more obvious?


Find the answers at





1. AniGenics

2. Applied Metacomputing

3. BASF-Lynx

4. Edinburgh Biocomputing Systems

5. eDNA

6. GeneSys Technologies

7. GenMatics

8. LabBook

9. Myriad Proteomics

10. PPGx, then DNA Sciences Laboratories

11. Ribozyme Pharmaceuticals

12. Secant Technologies

13. Soane BioSciences

14. TurboGenomics

15. Incyte Genomics

16. Indiana Proteomics Consortium

17. Blackstone Technologies and Blackstone Computing

18. GeneFormatics and Structural Bioinformatics

19. Molecular Simulations, Synopsys Scientific Systems, Oxford Molecular, and Genetics Computer Group

20. Variagenics and Hyseq

21. Pyrosequencing




A. ProSanos

B. Axaron Bioscience

C. Prolexys

D. TurboWorx

E. Rescentris

F. Avaki

G. Incyte

H. Accelrys

J. Waban Software

K. InProteo

L. Acero

M. Biotage

N. MJ Bioworks

O. OpGen

P. Argentys

Q. Sirna

R. Aneda

S Pyxis Genomics

T. Cengent Therapeutics

U. Nuvelo

V. Aclara


The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more